Literature DB >> 11292213

Do cognitively normal children with epilepsy have a higher rate of injury than their nonepileptic peers?

R Kirsch1, E Wirrell.   

Abstract

The objective of this study was to determine if cognitively normal children with epilepsy have higher accidental injury rates than their age- and sex-matched friends without epilepsy and what factors may predict this. Patients 5 to 16 years old, with a developmental quotient >70, without major motor or sensory impairments, with a 1-year history of epilepsy and who either had a seizure or had been on antiepileptic drugs within the past year, were identified from the pediatric neurology database of the Royal University Hospital. Twenty-five of 31 cases and their best friend controls agreed to participate. Seizure-related factors including type, duration, frequency, timing, date of diagnosis, antiepileptic drug initiation and discontinuation, and specific types and total antiepileptic drugs used were assessed by interview. Questionnaires about accidental injury including type, number, severity, and, if applicable, injuries resulting from seizures, as well as general safety practices, activity restrictions, and presence of attention-deficit hyperactivity disorder, were completed by cases and controls. No significant differences in injury numbers (specific types or total) or severity were found, although a small number of epileptic children were very predisposed to injury. Seizure-related factors did not predict injury in cases. Safety practices were similar, and restrictions in cases were not excessive. Children with attention-deficit hyperactivity disorder had a higher injury rate, both in cases and controls. Cognitively normal children with epilepsy do not have a higher injury rate than their nonepileptic peers. If consciousness is impaired in seizures, extra supervision for swimming and bathing and restricted climbing heights are suggested. All other safety restrictions for epileptic children should follow those appropriate to nonepileptic children to allow a normal lifestyle.

Entities:  

Mesh:

Year:  2001        PMID: 11292213     DOI: 10.1177/088307380101600206

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  7 in total

1.  Practical and analytical aspects of using friend controls in case-control studies: experience from a case-control study of childhood cancer.

Authors:  Greta R Bunin; Saran Vardhanabhuti; Agueda Lin; Greta L Anschuetz; Nandita Mitra
Journal:  Paediatr Perinat Epidemiol       Date:  2011-07-19       Impact factor: 3.980

2.  General surgery among long-term residents with and without active epilepsy at the Kork Epilepsy Centre - a prospective comparative one-year survey.

Authors:  Bernhard J Steinhoff; Ralph Hartmann; Matthias Luy; Angelika Rombach; Gerhard Ziegler; Jürgen Schulte-Mönting; Frank G Gilliam
Journal:  Eur Neurol       Date:  2010-08-03       Impact factor: 1.710

3.  Injuries in adolescents with childhood-onset epilepsy compared with sibling controls.

Authors:  Christine B Baca; Barbara G Vickrey; Stefanie D Vassar; Aaron Cook; Anne T Berg
Journal:  J Pediatr       Date:  2013-09-18       Impact factor: 4.406

Review 4.  Clinical practice: the treatment of acute convulsive seizures in children.

Authors:  Lieven Lagae
Journal:  Eur J Pediatr       Date:  2011-02-08       Impact factor: 3.183

Review 5.  Seizure-related injuries, drowning and vehicular crashes -- a critical review of the literature.

Authors:  Michael Tan; Wendyl D'Souza
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

6.  Injuries in epilepsy: a review of its prevalence, risk factors, type of injuries and prevention.

Authors:  Rita Nguyen; José F Téllez Zenteno
Journal:  Neurol Int       Date:  2009-11-16

7.  Educational and health outcomes of children and adolescents receiving antiepileptic medication: Scotland-wide record linkage study of 766 244 schoolchildren.

Authors:  Michael Fleming; Catherine A Fitton; Markus F C Steiner; James S McLay; David Clark; Albert King; Daniel F Mackay; Jill P Pell
Journal:  BMC Public Health       Date:  2019-05-17       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.